VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Future outcome

<< Previous

Bullboard Posts

Next >>

Post by bluemoons20on Sep 07, 2021 3:06pm

209 Views

Post# 33819835

Future outcome

Nice to see the volume picking up. Seems we only do well on higher volume.

Still have not heard what the reference to 19 is?? Is it the number of placements (free) already done , though no sales.

Also , not really enthusiastic about the comparison and $100 million buyout number, That kind of number would put us @ about 75 cents per share - long way from the recent wishful $4.

Anyone have some reasonable input into this???

GLTA

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources